Evaluation of Blood Results of Covid 19 Positive Pregnants

Official Title

Blood Results of Covid 19 Positive Pregnants

Brief Summary

Evaluation of blood results of covid 19 positive pregnant patients

Status

Active, not recruiting

Conditions

COVID19

Pregnancy Related

Interventions

Biological: Evaluation of blood results of covid 19 positive pregnant patients
peripheral blood values; hemogram, biochemistry (ast- sub-urea, creatinine, potassium, sodium, calcium, magnesium, vitamin d, homocysteine, ggt, crp)

Eligibility Criteria

Inclusion Criteria:

- pregnant

- covid19 positive

- no lung disease

Exclusion Criteria:

- with lung disease

- additional disease

- not pregnant pcr test negative

Eligibility Gender

Female

Eligibility Age

Minimum: 18 Years~Maximum: 45 Years

Countries

Turkey

NCT Number

NCT04337294

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Kanuni Sultan Suleyman Training and Research Hospital

Evaluation of Blood Results of Covid 19 Positive Pregnants

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA